Related Experiment Video
Updated: Jan 25, 2026
12:22
Speciation and Bioavailability Measurements of Environmental Plutonium Using Diffusion in Thin Films
Published on: November 9, 2015
11.8K
Evaluating 6PPD-Q bioavailability and biotransformation in zebrafish by diffusive gradients in thin-films
Suyu Ren1, Yuxiang Xia1, Mengfei Wang1
1School of Environmental and Material Engineering, Yantai University, Yantai, 264005, China.
Environmental Research
|January 23, 2026
Summary
Diffusive gradients in thin-films (DGT) technology accurately predicts 6PPD-Q bioavailability in zebrafish, overcoming limitations of traditional methods. DGT also effectively monitors 6PPD-Q metabolites, offering new insights into environmental behavior.
Area of Science:
- Environmental Chemistry
- Aquatic Toxicology
- Analytical Chemistry
Background:
- Assessing the bioavailability of 6PPD-Q is crucial for understanding its bioaccumulation and environmental risks in aquatic ecosystems.
- Traditional bioanalytical methods for 6PPD-Q face challenges in efficiency and field applicability.
- 6PPD-Q is an environmentally concerning substance with potential impacts on aquatic organisms.
Purpose of the Study:
- To evaluate the novel application of diffusive gradients in thin-films (DGT) technology for predicting 6PPD-Q bioavailability in zebrafish (Danio rerio).
- To compare the effectiveness of DGT with direct biological sampling for assessing 6PPD-Q and its metabolites.
- To investigate the bioaccumulation and biotransformation of 6PPD-Q in zebrafish and characterize metabolite release kinetics.
Main Methods:
- Simultaneous exposure of zebrafish and DGT devices to solutions with varying 6PPD-Q concentrations (5-100 μg L⁻¹).
- Utilizing high-resolution liquid chromatography-mass spectrometry to identify and quantify 6PPD-Q and its metabolites in zebrafish and solution.
- Analyzing the correlation between DGT measurements and zebrafish 6PPD-Q concentrations.
Main Results:
- DGT accurately determined time-weighted average concentrations of 6PPD-Q, even with fluctuating levels.
- A strong positive correlation (R²=0.786-0.996) was observed between DGT measurements and zebrafish concentrations at environmentally relevant levels (1.90-20.8 μg L⁻¹).
- Four 6PPD-Q metabolites were identified in zebrafish, and DGT effectively captured their trace-level dynamics and release kinetics, outperforming direct sampling.
Conclusions:
- DGT technology is a reliable tool for predicting 6PPD-Q bioavailability in aquatic organisms like zebrafish.
- DGT offers superior sensitivity and kinetic profiling for detecting hydrophobic organic pollutants and their metabolites compared to traditional methods.
- This study pioneers DGT application for assessing 6PPD-Q bioavailability and metabolite release, providing critical insights into its environmental behavior.
Related Concept Videos
01:12Diffusion
217.1K
Diffusion is the passive movement of substances down their concentration gradients—requiring no expenditure of cellular energy. Substances, such as molecules or ions, diffuse from an area of high concentration to an area of low concentration in the cytosol or across membranes. Eventually, the concentration will even out, with the substance moving randomly but causing no net change in concentration. Such a state is called dynamic equilibrium, which is essential for maintaining overall...
217.1K
01:26What is an Electrochemical Gradient?
127.5K
Adenosine triphosphate, or ATP, is considered the primary energy source in cells. However, energy can also be stored in the electrochemical gradient of an ion across the plasma membrane, which is determined by two factors: its chemical and electrical gradients.
The chemical gradient relies on differences in the abundance of a substance on the outside versus the inside of a cell and flows from areas of high to low ion concentration. In contrast, the electrical gradient revolves around an...
The chemical gradient relies on differences in the abundance of a substance on the outside versus the inside of a cell and flows from areas of high to low ion concentration. In contrast, the electrical gradient revolves around an...
127.5K
01:16Drug Biotransformation: Overview
3.7K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.7K
01:28Drug Biotransformation: Overview
2.5K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.5K
01:19Factors Affecting Drug Biotransformation: Biological
533
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
533
01:27Bioavailability Study Design: Absolute Versus Relative Bioavailability
322
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
322